Skip to playerSkip to main content
  • 1 year ago
The FDA on Tuesday recommended classifying 7-OH as a Schedule I controlled substance, according to NBC News. The synthetic compound has opioid-like effects and is found in unregulated products sold at gas stations and online. The agency warned that 7-OH, often misrepresented as kratom, may be more potent than morphine and linked to seizures, organ damage, and deaths. The DEA will now review the recommendation, which could restrict or prohibit the sale of 7-OH products. Deputy Secretary of Health and Human Services Jim O’Neill warned of a sharp rise in overdoses, poisonings, and ER visits tied to 7-OH products. He said these products are often sold without dosage controls or safety warnings, calling the situation a public health disaster. Kratom advocates pushed back, saying the real-world danger remains unproven.

Category

🗞
News
Transcript
00:00It's Benzinga, bringing Wall Street to Main Street.
00:02The FDA had Tuesday recommended classifying 7-OH as a Schedule I controlled substance,
00:07according to NBC News.
00:08The synthetic compound has opioid-like effects and is found in unregulated products
00:12on the gas stations and online.
00:14Agency warned that 7-OH, often misrepresented as Kratom,
00:18may be more potent than morphine linked to seizures, organ damage, and deaths.
00:22The DEA will now review the recommendation,
00:24which could restrict or prevent the sale of 7-OH products.
00:27The Deputy Secretary of Health and Human Services Jim O'Neill warned of a sharp rise in overdoses,
00:32poisonings, and ER visits tied to 7-OH products.
00:35He said these products are often sold without dosage controls or safety warnings,
00:38calling the situation a public health disaster.
00:41Kratom advocates pushed back, saying the real-world danger remains unproven.
00:45For all things money, visit Benzinga.com.
Comments

Recommended